| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 136.23B | 170.79B | 111.79B | 55.70B | 46.09B | 38.11B |
| Gross Profit | 32.42B | 39.27B | 25.46B | 12.96B | 10.86B | 9.30B |
| EBITDA | 15.35B | 21.10B | 14.23B | 7.37B | 6.19B | 5.23B |
| Net Income | 2.21B | 3.66B | 3.30B | 4.18B | 3.49B | 2.73B |
Balance Sheet | ||||||
| Total Assets | 180.05B | 222.21B | 114.37B | 52.81B | 31.45B | 27.10B |
| Cash, Cash Equivalents and Short-Term Investments | 26.57B | 32.47B | 25.65B | 12.38B | 7.09B | 7.32B |
| Total Debt | 85.26B | 106.22B | 51.28B | 18.56B | 11.09B | 11.54B |
| Total Liabilities | 120.97B | 157.03B | 78.67B | 33.15B | 20.21B | 19.36B |
| Stockholders Equity | 58.98B | 65.06B | 35.48B | 19.43B | 11.23B | 7.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -12.96B | -3.41B | 2.88B | 2.75B | 2.05B |
| Operating Cash Flow | 0.00 | 13.47B | 7.89B | 7.60B | 6.45B | 4.69B |
| Investing Cash Flow | 0.00 | -71.64B | -19.73B | -10.33B | -5.52B | -3.42B |
| Financing Cash Flow | 0.00 | 64.96B | 25.24B | 7.96B | -1.16B | 996.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥173.08B | 12.35 | ― | 3.40% | 6.12% | -3.75% | |
67 Neutral | ¥247.55B | 29.55 | ― | 1.51% | 11.92% | 33.70% | |
62 Neutral | ¥2.71T | 18.69 | 15.67% | 1.94% | 9.86% | -1.06% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥4.47T | 23.18 | 12.54% | 0.48% | 10.59% | 13.93% | |
53 Neutral | ¥113.40B | 32.53 | ― | ― | 62.69% | -37.72% | |
52 Neutral | ¥47.52B | 49.41 | ― | ― | 6.00% | -184.09% |